Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
09/2012
09/19/2012CN102266327B Application of 1-(4-tert-butyl benzyl)-3-(4-chlorphenyl)-1H-pyrazol-5-carbohydrazide in preparation of medicaments
09/19/2012CN102138944B Method for preparing ginkgo biloba extract dispersible tablets
09/19/2012CN102058531B Preparation method of fat emulsion of cerebral protection therapeutic drug
09/19/2012CN101991663B Liquid total paeony glycoside composite and preparation method thereof
09/19/2012CN101851209B Imidazole ethyl vanillic acid ether, preparation method and medicinal application thereof
09/19/2012CN101796039B Phenylacetic acid compound
09/19/2012CN101745013B Extraction method for ginseng, ophiopogon root and schisandra chinensis and preparation thereof
09/19/2012CN101745012B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
09/19/2012CN101745011B Method for extracting ginseng, dwarf lilyturf tuber and schisandra chinensis and preparation thereof
09/19/2012CN101745004B Method for extracting radix ophiopogonis, ginseng and schisandra chinensis as well as preparation thereof
09/19/2012CN101745003B Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
09/19/2012CN101745002B Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
09/19/2012CN101745001B Extraction method of ophiopogon root, ginseng and shiandra and preparation thereof
09/19/2012CN101745000B Extraction method of ginseng, ophiopogon root and shiandra and preparation thereof
09/19/2012CN101479291B Amino derivatives of B-homoandrostanes and B-heteroandrostanes
09/18/2012US8269027 Bipolar trans carotenoid salts and their uses
09/18/2012US8268893 Use of dapsone as a neuroprotector in cerebral infarction
09/18/2012US8268873 Inhibitors of IMPDH enzyme
09/18/2012US8268857 Compositions and methods for inhibiting TGF-β
09/18/2012US8268842 Fused ring 4-oxopyrimidine derivative
09/18/2012US8268839 Compounds
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268829 Substituted pyrimidines useful as protein kinase inhibitors
09/18/2012US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012CA2566754C Process for the preparation of perindopril and salts thereof
09/18/2012CA2521069C Pyrrolidino-1,2-dicarboxy-1-(phenylamide)-2-(4-(3-oxo-morpholino-4-yl)-phenylamide) derivatives and related compounds for use as inhibitors of coagulation factor xa in the treatment of thrombo-embolic diseases
09/18/2012CA2515259C Use of acetylsalicylic acid for the treatment of hemorrhoidal disease
09/18/2012CA2514303C Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use
09/18/2012CA2492855C Myocardial perfusion imaging using a2a receptor agonists
09/18/2012CA2490993C Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparations and uses thereof
09/18/2012CA2490986C Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof
09/18/2012CA2479659C Choline-silicic acid complex with osmolytes and divalent trace elements
09/18/2012CA2462610C Specific binding agents of human angiopoietin-2
09/18/2012CA2443302C Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles
09/18/2012CA2405731C Compositions and methods for improving vascular health
09/18/2012CA2383136C Obg3 globular head and uses thereof for decreasing body mass
09/18/2012CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia
09/18/2012CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof
09/13/2012WO2012122447A1 Methods of using microrna-26a to promote angiogenesis
09/13/2012WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same
09/13/2012WO2012122340A1 Soluble guanylate cyclase activators
09/13/2012WO2012122334A2 Procollagen carboxy-terminal propeptides as a target and treatment for angiogenesis related diseases
09/13/2012WO2012121971A2 Locally released growth factors to mediate motor recovery after stroke
09/13/2012WO2012121596A1 Use of vanadium compounds for maintaining normaglycemia in a mammal
09/13/2012WO2012121314A1 Dipyridylamine derivative
09/13/2012WO2012120262A1 Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
09/13/2012WO2012120128A1 Factor xii inhibitors for the administration with medical procedures comprising contact with artificial surfaces
09/13/2012WO2012120124A1 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs
09/13/2012WO2012119979A1 1H-PYROLLO[3,2-d]PYRIMIDINEDIONE DERIVATIVES
09/13/2012WO2012119978A1 Quinolinone derivatives
09/13/2012WO2012119560A1 Preparation method for extractive of jinxuan hemorrhoid washing powder botanicals
09/13/2012WO2012092395A3 Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio) acetic acid and uses thereof
09/13/2012WO2012090043A8 Novel solid state forms of azilsartan medoxomil and preparation thereof
09/13/2012WO2012087182A3 Substituted methyl amines, serotonin 5-ht6 receptor antagonists, methods for the production and use thereof
09/13/2012WO2012078859A3 Protein kinase d inhibitors
09/13/2012US20120232463 De novo synthesis of bacteriochlorins
09/13/2012US20120232157 Methods of using derivatives of (-)-venlafaxine
09/13/2012US20120232141 Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
09/13/2012US20120232122 Tricyclic heterocyclic derivatives
09/13/2012US20120232120 Amino acid amides of phenoxybutyric acid derivatives
09/13/2012US20120232116 Novel fxr (nr1h4) binding and activity modulating compounds
09/13/2012US20120232112 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
09/13/2012US20120232107 Non-peptide antagonists of gastrin releasing peptide
09/13/2012US20120232104 Novel sulfonamides as l-cpt1 inhibitors
09/13/2012US20120232101 Novel Compounds
09/13/2012US20120232100 Solid forms of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, and their pharmaceutical compositions and uses
09/13/2012US20120232098 Methods of predicting and treating adverse cardiac events
09/13/2012US20120232097 Cinnamoyl-piperazine derivatives and their use as par-1 antagonists
09/13/2012US20120232096 Benzofuran derivatives
09/13/2012US20120232095 Benzofuran derivatives
09/13/2012US20120232093 Pyrazole derivatives as sigma receptor inhibitors
09/13/2012US20120232092 Heterocyclic sulfonamides
09/13/2012US20120232091 Polymorphic Forms of Manidipine
09/13/2012US20120232081 Cyclic (aza)indolizinecarboxamides, their preparation and their use as pharmaceuticals
09/13/2012US20120232080 Phenoxy acetic acids as ppar delta activators
09/13/2012US20120232075 Fused Pyrazine Compounds Useful for the Treatment of Degenerative and Inflammatory Diseases
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232068 Quinazolines as potassium ion channel inhibitors
09/13/2012US20120232067 Benzodiazepinone compounds and methods of treatment using same
09/13/2012US20120232064 Aspartyl protease inhibitors
09/13/2012US20120232061 Novel compounds
09/13/2012US20120232058 Substituted pyridine derivatives and their medical use
09/13/2012US20120232055 Hydroxylated and methoxylated pyrimidyl cyclopentanes as akt protein kinase inhibitors
09/13/2012US20120232050 Cyclic Inhibitors of 11 beta-Hydroxysteroid Dehydrogenase 1
09/13/2012US20120232046 Method and kit for reducing the symptoms of peripheral vascular disease
09/13/2012US20120232041 Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial ischemia
09/13/2012US20120232039 Primary amine diazeniumdiolate heterocyclic derivatives
09/13/2012US20120232031 Injectable formulations for intra-articular or peri-articular administration
09/13/2012US20120232030 Heat stable hyaluronic acid compositions for dermatological use
09/13/2012US20120232028 Bicyclic Compound, Production and Use Thereof
09/13/2012US20120232012 Compositions having antiangiogenic activity and uses thereof
09/13/2012US20120232008 Plgf-1 in homodimeric form
09/13/2012US20120231994 Antagonism of human formyl peptide receptor for treatment of disease
09/13/2012US20120231095 Agents derived from holoptelea integrifolia and their compositions for the control of metabolic syndrome and associated diseases
09/13/2012US20120231085 Controlled release compositions of gamma-hydroxybutyrate
09/13/2012US20120231062 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
09/13/2012US20120231037 Crystalline drug-containing coatings
09/13/2012US20120231018 Heterocyclic aspartyl protease inhibitors
1 ... 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 ... 1595